Article Text

Download PDFPDF

Multiple myeloma presenting as clival mass: a diagnostic dilemma
Free
  1. Pradeep Venkataswamy Reddy1,
  2. Vikram Singh1,
  3. Ravi Roy2 and
  4. Uday Yanamandra3
  1. 1Dept of Pathology, Army Hospital Research and Referral, New Delhi, Delhi, India
  2. 2Department of ENT and Head and Neck Surgery, Army Hospital Research and Referral, New Delhi, India
  3. 3Department of Clinical Haematology, Army Hospital Research and Referral, New Delhi, India
  1. Correspondence to Dr Vikram Singh; vikram8165n{at}gmail.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Description

Multiple myeloma (MM) is characterised by proliferation of clonal plasma cells. At presentation, extramedullary MM is found in approximately 7% of patients, whereas another 6% may develop extramedullary lesions later in their disease course.1 2 Solitary plasmacytomas or multiple myeloma can present in the sellar and parasellar region in less than 1% of cases.3–5 Clival tumours are also extremely rare with an overall incidence of 0.1%–0.2% of all intracranial tumours, which predominantly includes clival chordoma and chondrosarcoma. We report an unusual presentation of multiple myeloma presenting as clival mass with neuro-ophthalmological involvement.

A 52-year-old man presented with complaints of diplopia in the left eye for 6 months, right hemicranial headache for 2 months and mucopurulent discharge from the right ear. He also had a history of hearing loss for 6 months. Examination revealed pallor, and left fourth and bilateral sixth cranial nerve palsies.

On evaluation at presentation, his haematological parameters were normal (haemoglobin, 145 g/L; total leucocyte count, 4.7×109/L; platelet count, 252×109/L). The biochemical parameters at presentation were blood urea nitrogen of 11 mg/dL, serum creatinine of 0.24 mg/dL and corrected serum calcium of 9.6 mg/dL. MRI of the brain and orbit revealed clival mass involving the left cavernous sinus measuring 5.8×3.9×3.1 mm and multiple lytic lesions of the skull (figure 1A–C). Positron emission tomography with CT scan revealed fluorodeoxyglucose avid lesions in the clival region and skeleton (sternum and skull). Paraproteinaemia evaluation revealed light chain disease (serum protein electrophoresis: faint band in Kappa region, Kappa (κ)=2320 mg/L, Lambda (λ)=21.3 mg/L with κ/λ ratio of 108.92, beta-2-microglobulin=2412 ng/dL). Bone marrow examination revealed cellular marrow with no increase in plasma cells.

Figure 1

Radiological findings and per-operative finding. (A, B) MRI axial and sagittal views showing the extent of tumour, anteriorly occupying the sphenoid sinus with lateral extent into bilateral cavernous sinuses and invasion of bilateral petrous apex with complete involvement of the clivus. (C) Axial view bone window shows multiple lytic lesions in the right parietal bone (marked by blue arrows). (D) Endoscopic picture of the smooth lobulated vascular lesion in the sphenoid sinus.

During transnasal endoscopic biopsy, he was found to have soft lobulated vascular mass occupying the sphenoid sinus with complete erosion of the clivus (figure 1D). Microscopic examination revealed mature and immature plasma cells in sheets (figure 2A,B). On immunohistochemical panel, these cells were positive for CD38, CD138 (figure 2C,D) and Kappa (figure 2E), and Lambda (figure 2F) immunostains showed Kappa restriction. Ki-67 index was 15%–20% (figure 2G). Tumour cells were negative for leucocyte common antigen, CD3, CD20, pancytokeratin and synaptophysin.

Figure 2

H&E and immunohistochemistry (IHC) photomicrographs. (A, B) Section shows the presence of tumour arranged in sheet comprising mature-appearing plasma cells (H&E stain, 20×). (C) Few immature plasma cells are also seen with high nucleus:cytoplasm ratio and conspicuous nucleoli (H&E stain, 4020×). (D–H) Photomicrographs showing IHC results: tumour cells were positive for CD138 (D), CD38 (E) and Kappa (F) but negative for Lambda immunostain (G), and Ki67 index was high, that is, 25%–30% (H).

Based on these findings, the diagnosis of MM with clival plasmacytoma (C–R–A–B+) R-ISS III was made. The patient was treated with VCD chemotherapy (injection of bortezomib, injection of dexamethasone and injection of thalidomide daily) along with local palliative radiotherapy, and he is responding well.

MM presenting as clival mass can create a great diagnostic dilemma because these patients first come to ENT or neurosurgery OPDs. In a systemic review of 65 cases of sellar and clival plasmacytoma, 16% had a history of known MM, whereas 37% were diagnosed concurrently with MM presenting with parasellar plasmacytoma.6 High index of suspicion supported by an appropriate IHC panel is essential to arrive at the correct histological diagnosis, and then a multidisciplinary team approach is critical to achieve best therapeutic outcomes.

Learning points

  • Extramedullary presentation of multiple myeloma as clival mass is rare.

  • Radiologically and clinically, it can mimic other more common clival lesions.

  • Tissue biopsy is important because plasma cell dyscrasias are fairly common, and biopsy may be required to differentiate plasmacytoma from any other clival tumours with incidental Monoclonal gammopathy of undetermined significance (MGUS).

  • High index of suspicion and thorough haematological workup are required to reach the correct diagnosis.

Ethics statements

Patient consent for publication

References

Footnotes

  • Contributors PVR, Pathology Resident, conceptualised and prepared the manuscript. VS, Pathologist, conceptualised and prepared the manuscript. RR, Treating ENT surgeon, supervised the manuscript. UY, Treating Physician, supervised the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.